Vascularization Pattern After Ischemic Stroke is Different in Control Versus Diabetic Rats: Relevance to Stroke Recovery
暂无分享,去创建一个
[1] T. Dawber,et al. The Framingham Study , 2014 .
[2] A. Ergul,et al. Cerebral Neovascularization and Remodeling Patterns in Two Different Models of Type 2 Diabetes , 2013, PloS one.
[3] A. Ergul,et al. Angiogenesis: A Harmonized Target for Recovery After Stroke , 2012, Stroke.
[4] R. Knight,et al. Cerebral Myogenic Reactivity and Blood Flow in Type 2 Diabetic Rats: Role of Peroxynitrite in Hypoxia-Mediated Loss of Myogenic Tone , 2012, Journal of Pharmacology and Experimental Therapeutics.
[5] A. Ergul,et al. Enhanced Cerebral but Not Peripheral Angiogenesis in the Goto-Kakizaki Model of Type 2 Diabetes Involves VEGF and Peroxynitrite Signaling , 2012, Diabetes.
[6] Kelly A. Tennant,et al. Diabetes Impairs Cortical Plasticity and Functional Recovery Following Ischemic Stroke , 2012, The Journal of Neuroscience.
[7] S. Kiechl,et al. Functional recovery after ischemic stroke—A matter of age , 2012, Neurology.
[8] Debraj Mukherjee,et al. Epidemiology and the global burden of stroke. , 2011, World neurosurgery.
[9] Christos Davatzikos,et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy , 2011, The Lancet Neurology.
[10] Anthony S. Kim,et al. Global Variation in the Relative Burden of Stroke and Ischemic Heart Disease , 2011, Circulation.
[11] P. Wolf,et al. Inflammatory Markers and Neuropsychological Functioning: The Framingham Heart Study , 2011, Neuroepidemiology.
[12] E. Syková,et al. Astroglial networks scale synaptic activity and plasticity , 2011, Proceedings of the National Academy of Sciences.
[13] M. Endres,et al. Changes in Cognitive Function over 3 Years after First-Ever Stroke and Predictors of Cognitive Impairment and Long-Term Cognitive Stability: The Erlangen Stroke Project , 2011, Dementia and Geriatric Cognitive Disorders.
[14] M. Hiltunen,et al. Chronic Hyperperfusion and Angiogenesis Follow Subacute Hypoperfusion in the Thalamus of Rats with Focal Cerebral Ischemia , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[15] A. Ergul,et al. Vascular Protection in Diabetic Stroke: Role of Matrix Metalloprotease-Dependent Vascular Remodeling , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[16] J. Krupiński,et al. Angiogenesis, Neurogenesis and Neuroplasticity in Ischemic Stroke , 2010, Current cardiology reviews.
[17] Meijia Zhu,et al. The possible mechanism for impaired angiogenesis after transient focal ischemia in type 2 diabetic GK rats: different expressions of angiostatin and vascular endothelial growth factor. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[18] M. Chopp,et al. Angiogenesis, neurogenesis and brain recovery of function following injury. , 2010, Current opinion in investigational drugs.
[19] A. Ergul,et al. Adaptive Cerebral Neovascularization in a Model of Type 2 Diabetes , 2009, Diabetes.
[20] K. Arai,et al. Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke , 2009, The FEBS journal.
[21] A. Ergul,et al. Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature. , 2009, Vascular pharmacology.
[22] L. Rinaldi,et al. Recovery from stroke in patients with diabetes mellitus. , 2009, Journal of diabetes and its complications.
[23] H. Elewa,et al. Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke. , 2009, Stroke.
[24] M. Chopp,et al. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic , 2009, The Lancet Neurology.
[25] A. Dorrance,et al. Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.
[26] V. Gudnason,et al. American Journal of Epidemiology Original Contribution Cognitive Impairment: an Increasingly Important Complication of Type 2 Diabetes the Age, Gene/environment Susceptibility–reykjavik Study , 2022 .
[27] P. Gæde. Intensive glucose control and cardiovascular disease in type 2 diabetes--should we change the recommended target for glycated hemoglobin? Commentary to ACCORD and ADVANCE trials. , 2008 .
[28] E. V. van Dijk,et al. Progression of Cerebral Small Vessel Disease in Relation to Risk Factors and Cognitive Consequences: Rotterdam Scan Study , 2008, Stroke.
[29] A. Hofman,et al. Total Cerebral Blood Flow in Relation to Cognitive Function: The Rotterdam Scan Study , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[30] O. Pedersen,et al. Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes. , 2008, European journal of endocrinology.
[31] M. Chopp,et al. Plasticity and remodeling of brain , 2008, Journal of the Neurological Sciences.
[32] A. Favier,et al. Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin. , 2008, Clinical science.
[33] Jerry Silver,et al. The role of extracellular matrix in CNS regeneration , 2007, Current Opinion in Neurobiology.
[34] J. Broderick,et al. Intracranial Hemorrhage Associated With Revascularization Therapies , 2007, Stroke.
[35] M. Chopp,et al. Neurogenesis, Angiogenesis, and MRI Indices of Functional Recovery From Stroke , 2007, Stroke.
[36] J. Krupiński,et al. Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. , 2006, Clinical science.
[37] N. Wiernsperger,et al. Metformin delays the manifestation of diabetes and vascular dysfunction in Goto–Kakizaki rats by reduction of mitochondrial oxidative stress , 2006, Diabetes/metabolism research and reviews.
[38] Ralph B. D’Agostino,et al. Obesity, diabetes and cognitive deficit: The Framingham Heart Study , 2005, Neurobiology of Aging.
[39] Ann M. Stowe,et al. Extensive Cortical Rewiring after Brain Injury , 2005, The Journal of Neuroscience.
[40] Benjamin J. Kraus,et al. Impaired Revascularization in a Mouse Model of Type 2 Diabetes Is Associated With Dysregulation of a Complex Angiogenic-Regulatory Network , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[41] D. Ziegler,et al. Stroke in patients with diabetes mellitus , 2004, Diabetes/metabolism research and reviews.
[42] J. Sowers,et al. Stroke in Patients With Diabetes , 2004, Journal of clinical hypertension.
[43] M. Chopp,et al. Microvascular structure after embolic focal cerebral ischemia in the rat , 2003, Brain Research.
[44] A. Tuttolomondo,et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. , 2003, Stroke.
[45] Shu-Wei Sun,et al. Dynamic Changes in Cerebral Blood Flow and Angiogenesis After Transient Focal Cerebral Ischemia in Rats: Evaluation With Serial Magnetic Resonance Imaging , 2002, Stroke.
[46] W. Duckworth. Hyperglycemia and cardiovascular disease , 2001, Current atherosclerosis reports.
[47] R. Nudo,et al. Role of adaptive plasticity in recovery of function after damage to motor cortex , 2001, Muscle & nerve.
[48] S. Vannucci,et al. Experimental Stroke in the Female Diabetic, db/db, Mouse , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[49] R. Holman,et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.
[50] M. Laakso,et al. Hyperglycemia and cardiovascular disease in type 2 diabetes. , 1999, Diabetes.
[51] C. Wolfe,et al. Variations in case fatality and dependency from stroke in western and central Europe. The European BIOMED Study of Stroke Care Group. , 1999, Stroke.
[52] R. Holman,et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.
[53] R. D'Agostino,et al. NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study , 1997, Diabetes Care.
[54] T. Olsen,et al. Stroke in Patients With Diabetes The Copenhagen Stroke Study , 1994, Stroke.
[55] M. Nishimura,et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. , 1986, Stroke.
[56] G. Schernthaner. Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR , 2010, Wiener Medizinische Wochenschrift.
[57] L. Mogoantă,et al. Study of vascular microdensity in areas of cerebral ischemia on experimental model. , 2010, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[58] P. Gaede. Intensive glucose control and cardiovascular disease in type 2 diabetes--should we change the recommended target for glycated hemoglobin? Commentary to ACCORD and ADVANCE trials. , 2008, Polskie Archiwum Medycyny Wewnetrznej.
[59] J. Krupiński,et al. Cerebral Ischemic Stroke , 2005 .